Publication | Open Access

Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies

Medicinal ChemistryBiochemistryMedicineNatural SciencesGuanidine DerivativesMolecular Modeling StudiesAnti-cancer AgentDrug DevelopmentPharmacologyPharmaceutical ChemistryInhibitory ActivityAnticancer ActivityDrug Discovery